BioAge Labs BIOA
NASDAQ BIOA
$9.73 -1.02 (-9.44%)
At close: Aug 20, 2026 · 2:02 PM UTC

BioAge Labs (BIOA) Other Non Operating Income (2024)

BioAge Labs (BIOA) posted Other Non Operating Income of -$250000.0 for Q1 2024.

BioAge Labs (BIOA) Other Non Operating Income (2024) Analysis & Trends

BioAge Labs has reported Other Non Operating Income for 1 years, with the latest figure at -$250000.0 in Q1 2024.

  • Quarterly Other Non Operating Income changed N/A year-over-year to -$250000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was -$250000.0 (changed N/A YoY) and the FY2024 annual result came in at -$250000.0, changed N/A from the prior year.
  • Other Non Operating Income was little changed at -$250000.0 in Q1 2024 per BIOA's latest filing.
  • Over five years, Other Non Operating Income peaked at -$250000.0 in Q1 2024 and troughed at -$250000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 BioAge Labs 436.51 Mn 436.51 Mn -14.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 -250,000.00